25 XP   0   0   10

Avivagen Inc
Buy, Hold or Sell?

Let's analyse Avivagen together

PenkeI guess you are interested in Avivagen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Avivagen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Avivagen Inc

I send you an email if I find something interesting about Avivagen Inc.

Quick analysis of Avivagen (30 sec.)










What can you expect buying and holding a share of Avivagen? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$-0.08
Expected worth in 1 year
C$-0.18
How sure are you?
22.2%

+ What do you gain per year?

Total Gains per Share
C$-0.10
Return On Investment
-1,045.8%

For what price can you sell your share?

Current Price per Share
C$0.01
Expected price per share
C$0.01 - C$0.01
How sure are you?
50%

1. Valuation of Avivagen (5 min.)




Live pricePrice per Share (EOD)

C$0.01

Intrinsic Value Per Share

C$-0.27 - C$-0.22

Total Value Per Share

C$-0.35 - C$-0.29

2. Growth of Avivagen (5 min.)




Is Avivagen growing?

Current yearPrevious yearGrowGrow %
How rich?-$4.3m-$2.8m-$1.4m-33.9%

How much money is Avivagen making?

Current yearPrevious yearGrowGrow %
Making money-$4.4m-$4.6m$239.2k5.4%
Net Profit Margin-645.9%-493.4%--

How much money comes from the company's main activities?

3. Financial Health of Avivagen (5 min.)




What can you expect buying and holding a share of Avivagen? (5 min.)

Welcome investor! Avivagen's management wants to use your money to grow the business. In return you get a share of Avivagen.

What can you expect buying and holding a share of Avivagen?

First you should know what it really means to hold a share of Avivagen. And how you can make/lose money.

Speculation

The Price per Share of Avivagen is C$0.01. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Avivagen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Avivagen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$-0.08. Based on the TTM, the Book Value Change Per Share is C$-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Avivagen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.06-569.7%-0.06-569.7%-0.06-600.4%-0.05-504.9%-0.04-405.3%
Usd Book Value Change Per Share-0.02-190.7%-0.02-190.7%0.0176.5%-0.01-115.6%-0.01-62.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-190.7%-0.02-190.7%0.0176.5%-0.01-115.6%-0.01-62.4%
Usd Price Per Share0.10-0.10-0.29-0.30-0.27-
Price to Earnings Ratio-1.79--1.79--4.86--6.21--6.18-
Price-to-Total Gains Ratio-5.35--5.35-38.13--132.44--111.82-
Price to Book Ratio-1.82--1.82--7.86-100.59-110.17-
Price-to-Total Gains Ratio-5.35--5.35-38.13--132.44--111.82-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.007296
Number of shares137061
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.02-0.01
Usd Total Gains Per Share-0.02-0.01
Gains per Quarter (137061 shares)-2,614.40-1,583.81
Gains per Year (137061 shares)-10,457.59-6,335.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-10458-104680-6335-6345
20-20915-209260-12670-12680
30-31373-313840-19006-19015
40-41830-418420-25341-25350
50-52288-523000-31676-31685
60-62746-627580-38011-38020
70-73203-732160-44347-44355
80-83661-836740-50682-50690
90-94118-941320-57017-57025
100-104576-1045900-63352-63360

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.09.00.00.0%0.09.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.07.00.022.2%2.07.00.022.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.07.00.022.2%2.07.00.022.2%

Fundamentals of Avivagen

About Avivagen Inc

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

Fundamental data was last updated by Penke on 2024-04-05 05:04:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Avivagen Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Avivagen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -645.9% means that $-6.46 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avivagen Inc:

  • The MRQ is -645.9%. The company is making a huge loss. -2
  • The TTM is -645.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-645.9%TTM-645.9%0.0%
TTM-645.9%YOY-493.4%-152.5%
TTM-645.9%5Y-497.6%-148.3%
5Y-497.6%10Y-903.4%+405.7%
1.1.2. Return on Assets

Shows how efficient Avivagen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • -444.3% Return on Assets means that Avivagen generated $-4.44 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avivagen Inc:

  • The MRQ is -444.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -444.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-444.3%TTM-444.3%0.0%
TTM-444.3%YOY-183.9%-260.4%
TTM-444.3%5Y-251.6%-192.7%
5Y-251.6%10Y-235.3%-16.3%
1.1.3. Return on Equity

Shows how efficient Avivagen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Avivagen generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avivagen Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-1,030.9%+1,030.9%
5Y-1,030.9%10Y-987.2%-43.8%

1.2. Operating Efficiency of Avivagen Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Avivagen is operating .

  • Measures how much profit Avivagen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -521.5% means the company generated $-5.21  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avivagen Inc:

  • The MRQ is -521.5%. The company is operating very inefficient. -2
  • The TTM is -521.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-521.5%TTM-521.5%0.0%
TTM-521.5%YOY-316.9%-204.5%
TTM-521.5%5Y-382.2%-139.3%
5Y-382.2%10Y-815.4%+433.2%
1.2.2. Operating Ratio

Measures how efficient Avivagen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 3.21 means that the operating costs are $3.21 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avivagen Inc:

  • The MRQ is 3.207. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.207. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.207TTM3.2070.000
TTM3.207YOY4.757-1.550
TTM3.2075Y4.628-1.422
5Y4.62810Y9.114-4.486

1.3. Liquidity of Avivagen Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Avivagen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.61 means the company has $0.61 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avivagen Inc:

  • The MRQ is 0.606. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.606. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.606TTM0.6060.000
TTM0.606YOY0.535+0.071
TTM0.6065Y1.246-0.640
5Y1.24610Y2.810-1.564
1.3.2. Quick Ratio

Measures if Avivagen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.23 means the company can pay off $0.23 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avivagen Inc:

  • The MRQ is 0.235. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.235. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.235TTM0.2350.000
TTM0.235YOY0.057+0.178
TTM0.2355Y0.167+0.068
5Y0.16710Y0.167-0.001

1.4. Solvency of Avivagen Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Avivagen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avivagen to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 5.38 means that Avivagen assets are financed with 538.3% credit (debt) and the remaining percentage (100% - 538.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Avivagen Inc:

  • The MRQ is 5.383. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 5.383. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ5.383TTM5.3830.000
TTM5.383YOY2.137+3.246
TTM5.3835Y2.881+2.502
5Y2.88110Y2.785+0.096
1.4.2. Debt to Equity Ratio

Measures if Avivagen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avivagen Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y6.431-6.431
5Y6.43110Y6.010+0.421

2. Market Valuation of Avivagen Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avivagen generates.

  • Above 15 is considered overpriced but always compare Avivagen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.79 means the investor is paying $-1.79 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avivagen Inc:

  • The EOD is -0.128. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.793. Based on the earnings, the company is expensive. -2
  • The TTM is -1.793. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.128MRQ-1.793+1.665
MRQ-1.793TTM-1.7930.000
TTM-1.793YOY-4.860+3.067
TTM-1.7935Y-6.207+4.414
5Y-6.20710Y-6.177-0.030
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Avivagen Inc:

  • The EOD is -0.249. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.490. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.490. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.249MRQ-3.490+3.241
MRQ-3.490TTM-3.4900.000
TTM-3.490YOY-6.745+3.255
TTM-3.4905Y-8.467+4.977
5Y-8.46710Y-7.765-0.703
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Avivagen is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Avivagen Inc:

  • The EOD is -0.130. Based on the equity, the company is expensive. -2
  • The MRQ is -1.818. Based on the equity, the company is expensive. -2
  • The TTM is -1.818. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.130MRQ-1.818+1.688
MRQ-1.818TTM-1.8180.000
TTM-1.818YOY-7.863+6.045
TTM-1.8185Y100.594-102.412
5Y100.59410Y110.170-9.576
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Avivagen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.026-0.0260%0.010-349%-0.016-39%-0.009-67%
Book Value Per Share---0.077-0.0770%-0.051-34%-0.046-40%-0.032-58%
Current Ratio--0.6060.6060%0.535+13%1.246-51%2.810-78%
Debt To Asset Ratio--5.3835.3830%2.137+152%2.881+87%2.785+93%
Debt To Equity Ratio----0%-0%6.431-100%6.010-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.078-0.0780%-0.082+5%-0.069-11%-0.056-29%
Free Cash Flow Per Share---0.040-0.0400%-0.059+48%-0.048+19%-0.042+4%
Free Cash Flow To Equity Per Share---0.014-0.0140%0.010-251%-0.003-76%-0.001-91%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.215--------
Intrinsic Value_10Y_min---0.271--------
Intrinsic Value_1Y_max---0.042--------
Intrinsic Value_1Y_min---0.043--------
Intrinsic Value_3Y_max---0.111--------
Intrinsic Value_3Y_min---0.117--------
Intrinsic Value_5Y_max---0.161--------
Intrinsic Value_5Y_min---0.175--------
Market Cap776947.040-1300%10877258.56010877258.5600%31077881.600-65%31854828.640-66%28833367.929-62%
Net Profit Margin---6.459-6.4590%-4.934-24%-4.976-23%-9.034+40%
Operating Margin---5.215-5.2150%-3.169-39%-3.822-27%-8.154+56%
Operating Ratio--3.2073.2070%4.757-33%4.628-31%9.114-65%
Pb Ratio-0.130+93%-1.818-1.8180%-7.863+333%100.594-102%110.170-102%
Pe Ratio-0.128+93%-1.793-1.7930%-4.860+171%-6.207+246%-6.177+244%
Price Per Share0.010-1300%0.1400.1400%0.400-65%0.410-66%0.371-62%
Price To Free Cash Flow Ratio-0.249+93%-3.490-3.4900%-6.745+93%-8.467+143%-7.765+122%
Price To Total Gains Ratio-0.382+93%-5.355-5.3550%38.135-114%-132.436+2373%-111.816+1988%
Quick Ratio--0.2350.2350%0.057+312%0.167+41%0.167+40%
Return On Assets---4.443-4.4430%-1.839-59%-2.516-43%-2.353-47%
Return On Equity----0%-0%-10.3090%-9.8720%
Total Gains Per Share---0.026-0.0260%0.010-349%-0.016-39%-0.009-67%
Usd Book Value---4365867.302-4365867.3020%-2883864.384-34%-2607098.650-40%-1825168.414-58%
Usd Book Value Change Per Share---0.019-0.0190%0.008-349%-0.012-39%-0.006-67%
Usd Book Value Per Share---0.056-0.0560%-0.037-34%-0.034-40%-0.023-58%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.057-0.0570%-0.060+5%-0.050-11%-0.041-29%
Usd Free Cash Flow---2273826.125-2273826.1250%-3361815.859+48%-2716228.570+19%-2360720.107+4%
Usd Free Cash Flow Per Share---0.029-0.0290%-0.043+48%-0.035+19%-0.030+4%
Usd Free Cash Flow To Equity Per Share---0.010-0.0100%0.007-251%-0.002-76%-0.001-91%
Usd Market Cap566860.560-1300%7936047.8457936047.8450%22674422.415-65%23241282.976-66%21036825.241-62%
Usd Price Per Share0.007-1300%0.1020.1020%0.292-65%0.299-66%0.271-62%
Usd Profit---4425903.898-4425903.8980%-4665178.406+5%-3922640.556-11%-3149815.582-29%
Usd Revenue--685220.621685220.6210%945555.034-28%797167.380-14%513924.646+33%
Usd Total Gains Per Share---0.019-0.0190%0.008-349%-0.012-39%-0.006-67%
 EOD+2 -6MRQTTM+0 -0YOY+10 -215Y+9 -2310Y+12 -20

3.2. Fundamental Score

Let's check the fundamental score of Avivagen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.128
Price to Book Ratio (EOD)Between0-1-0.130
Net Profit Margin (MRQ)Greater than0-6.459
Operating Margin (MRQ)Greater than0-5.215
Quick Ratio (MRQ)Greater than10.235
Current Ratio (MRQ)Greater than10.606
Debt to Asset Ratio (MRQ)Less than15.383
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-4.443
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Avivagen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.650
Ma 20Greater thanMa 500.010
Ma 50Greater thanMa 1000.010
Ma 100Greater thanMa 2000.010
OpenGreater thanClose0.010
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-10-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets1,365
Total Liabilities7,349
Total Stockholder Equity-5,984
 As reported
Total Liabilities 7,349
Total Stockholder Equity+ -5,984
Total Assets = 1,365

Assets

Total Assets1,365
Total Current Assets1,271
Long-term Assets94
Total Current Assets
Cash And Cash Equivalents 290
Net Receivables 493
Inventory 314
Other Current Assets 26
Total Current Assets  (as reported)1,271
Total Current Assets  (calculated)1,123
+/- 148
Long-term Assets
Property Plant Equipment 94
Long-term Assets  (as reported)94
Long-term Assets  (calculated)94
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,098
Long-term Liabilities5,251
Total Stockholder Equity-5,984
Total Current Liabilities
Short Long Term Debt 810
Accounts payable 911
Other Current Liabilities 64
Total Current Liabilities  (as reported)2,098
Total Current Liabilities  (calculated)1,785
+/- 314
Long-term Liabilities
Long term Debt 5,251
Capital Lease Obligations Min Short Term Debt24
Long-term Liabilities  (as reported)5,251
Long-term Liabilities  (calculated)5,276
+/- 24
Total Stockholder Equity
Common Stock34,895
Retained Earnings -45,195
Total Stockholder Equity (as reported)-5,984
Total Stockholder Equity (calculated)-10,299
+/- 4,315
Other
Capital Stock34,895
Common Stock Shares Outstanding 77,187
Net Debt 5,771
Net Invested Capital 77
Net Tangible Assets -5,984
Net Working Capital -827
Property Plant and Equipment Gross 447



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2022-10-312021-10-312020-10-312019-10-312018-10-312017-10-312016-10-312015-10-312014-10-31
> Total Assets 
869
693
5,196
1,850
3,109
1,888
2,176
3,478
1,365
1,3653,4782,1761,8883,1091,8505,196693869
   > Total Current Assets 
836
681
5,196
1,850
3,042
1,716
1,782
3,216
1,271
1,2713,2161,7821,7163,0421,8505,196681836
       Cash And Cash Equivalents 
769
632
5,142
1,600
2,207
1,086
664
1,408
290
2901,4086641,0862,2071,6005,142632769
       Net Receivables 
49
37
41
99
227
133
502
343
493
49334350213322799413749
       Inventory 
18
1
3
90
579
452
406
1,232
314
3141,232406452579903118
   > Long-term Assets 
0
0
0
0
67
172
394
262
94
94262394172670000
       Property Plant Equipment 
33
12
0
0
67
172
394
262
94
9426239417267001233
> Total Liabilities 
3,261
3,518
4,796
1,681
3,015
5,144
6,944
7,430
7,349
7,3497,4306,9445,1443,0151,6814,7963,5183,261
   > Total Current Liabilities 
158
280
628
604
1,010
1,302
2,352
6,014
2,098
2,0986,0142,3521,3021,010604628280158
       Short-term Debt 
14
1
147
78
140
648
0
0
0
00064814078147114
       Short Long Term Debt 
14
1
147
78
247
746
1,363
5,316
810
8105,3161,36374624778147114
       Accounts payable 
107
161
151
241
698
511
710
463
911
911463710511698241151161107
       Other Current Liabilities 
0
0
0
0
107
98
26
64
64
646426981070000
   > Long-term Liabilities 
0
0
4,167
1,077
2,005
3,842
4,592
1,417
5,251
5,2511,4174,5923,8422,0051,0774,16700
> Total Stockholder Equity
-2,392
-2,825
401
169
94
-3,256
-4,768
-3,953
-5,984
-5,984-3,953-4,768-3,25694169401-2,825-2,392
   Common Stock
11,699
12,676
18,119
19,910
22,964
23,957
26,555
31,823
34,895
34,89531,82326,55523,95722,96419,91018,11912,67611,699
   Retained Earnings -45,195-40,473-35,137-31,013-26,396-22,454-17,474-18,343-19,335
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
0
0
0
0
250
350
0
0
0
0003502500000



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2022-10-31)

Gross Profit (+$)
totalRevenue939
Cost of Revenue-539
Gross Profit400400
 
Operating Income (+$)
Gross Profit400
Operating Expense-2,473
Operating Income-1,534-2,073
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,897
Selling And Marketing Expenses0
Operating Expense2,4731,897
 
Net Interest Income (+$)
Interest Income1
Interest Expense-1,769
Other Finance Cost-599
Net Interest Income-1,168
 
Pretax Income (+$)
Operating Income-1,534
Net Interest Income-1,168
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,0661,830
EBIT - interestExpense = -6,666
-6,066
-4,298
Interest Expense1,769
Earnings Before Interest and Taxes (EBIT)-4,898-4,298
Earnings Before Interest and Taxes (EBITDA)-4,210
 
After tax Income (+$)
Income Before Tax-6,066
Tax Provision-0
Net Income From Continuing Ops-6,066-6,066
Net Income-6,066
Net Income Applicable To Common Shares-6,066
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses50
Total Other Income/Expenses Net-3,3641,168
 

Technical Analysis of Avivagen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Avivagen. The general trend of Avivagen is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Avivagen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Avivagen Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.01 < 0.01 < 0.01.

The bearish price targets are: 0.01 > 0.01 > 0.01.

Tweet this
Avivagen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Avivagen Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Avivagen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Avivagen Inc. The current macd is 0.0000.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Avivagen price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Avivagen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Avivagen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Avivagen Inc Daily Moving Average Convergence/Divergence (MACD) ChartAvivagen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Avivagen Inc. The current adx is 11.49.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Avivagen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Avivagen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Avivagen Inc. The current sar is 0.01044547.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Avivagen Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Avivagen Inc. The current rsi is 41.65. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Avivagen Inc Daily Relative Strength Index (RSI) ChartAvivagen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Avivagen Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Avivagen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Avivagen Inc Daily Stochastic Oscillator ChartAvivagen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Avivagen Inc. The current cci is -66.66666667.

Avivagen Inc Daily Commodity Channel Index (CCI) ChartAvivagen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Avivagen Inc. The current cmo is 0.

Avivagen Inc Daily Chande Momentum Oscillator (CMO) ChartAvivagen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Avivagen Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Avivagen Inc Daily Williams %R ChartAvivagen Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Avivagen Inc.

Avivagen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Avivagen Inc. The current atr is 0.0000.

Avivagen Inc Daily Average True Range (ATR) ChartAvivagen Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Avivagen Inc. The current obv is 1,085,000.

Avivagen Inc Daily On-Balance Volume (OBV) ChartAvivagen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Avivagen Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Avivagen Inc Daily Money Flow Index (MFI) ChartAvivagen Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Avivagen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

Avivagen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Avivagen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.650
Ma 20Greater thanMa 500.010
Ma 50Greater thanMa 1000.010
Ma 100Greater thanMa 2000.010
OpenGreater thanClose0.010
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Avivagen with someone you think should read this too:
  • Are you bullish or bearish on Avivagen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Avivagen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Avivagen Inc

I send you an email if I find something interesting about Avivagen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Avivagen Inc.

Receive notifications about Avivagen Inc in your mailbox!